http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009148583-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58794b34dc2f7bf943da7413ebda795a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d29ddc2c8de3fbff3672ca0f387c40d8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 |
| filingDate | 2009-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d4e5a33114ddc2b989e98bb3575e423 |
| publicationDate | 2009-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2009148583-A2 |
| titleOfInvention | Method for improvement of octreotide bioavailability |
| abstract | The invention provides a an octreotide sustained release delivery system for treatment of diseases ameliorated by octreotide compounds. The sustained release delivery system of the invention includes a flowable composition containing octreotide. Injection of the delivery system results in a biocompatible implant containing the octreotide. The flowable composition includes a poly(lactide-glycolide) copolymer compositions adapted for use in controlled release delivery systems, and exhibits favorable release kinetics for octreotide when implanted in patients. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015161841-A3 |
| priorityDate | 2008-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 842.